Abstracts tagged "Vitamin D and rheumatoid arthritis (RA)"

Abstract Number: 1920 • 2016 ACR/ARHP Annual Meeting
Vitamin D Induces a Type 1 Regulatory T Cell (Tr1)-like Phenotype in Human C-C Chemokine Receptor Type 6 (Ccr6)+ th Cells and Promotes Their Migration to an Inflammatory Environment
Wendy Dankers¹, Jan Piet van Hamburg¹, Nadine Davelaar¹, Patrick Asmawidjaja¹, Hoyan Wen¹, Johannes van Leeuwen², Edgar Colin³ and Erik Lubberts¹, ¹Rheumatology and Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, ²Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, Netherlands, ³Rheumatology, ZGT, Almelo, Netherlands
Background/Purpose: The active vitamin D metabolite 1,25(OH)2D3 suppresses various experimental autoimmune diseases. In addition, serum vitamin D levels, vitamin D intake and polymorphisms in the…
Abstract Number: 2678 • 2015 ACR/ARHP Annual Meeting
Vitamin D Serum Level in Early Arthritis Patients: Association with Disease Activity, Disability and Severity in the Espoir Cohort
Etienne Gamon¹, Gaël Mouterde², Cédric Lukas³, Mattea Orsini⁴, Raphaèle Seror⁵ and Bernard Combe⁶, ¹Immunologie Rhumatologie, Hopital Lapeyronie, Montpellier, France, ²Rheumatology Department, Hopital Lapeyronie, Montpellier, France, ³Hopital Lapeyronie, Montpellier, France, ⁴Epidemiology Unit, Hopital Lapeyronie, Montpellier, France, ⁵Rheumatology, AP-HP Bicêtre Hospital / Paris-Sud University, Le Kremlin-Bicêtre, France, ⁶Rheumatology, Hopital Lapeyronie, Montpellier, France
Background/Purpose: Environmental factors may play a crucial role in auto-immune diseases. Besides tobacco, other factors like vitamin D are suspected to impact the onset and…
Abstract Number: 1418 • 2014 ACR/ARHP Annual Meeting
Prevalence of Vitamin D Deficiency in Rheumatoid Arthritis
Stella Cecchetti¹, Martin Soubrier², Pilar Galan^3,4, Bruno Pereira⁵, Gael Mouterde⁶ and Maxime Dougados⁷, ¹Rheumatology department, CHU Gabriel Montpied, 63000, France, ²Rheumatology, CHU G.-Montpied, Clermont-Ferrand, France, ³Nutritional Epidemiology Research Unit, INSERM (U1153), Bobigny, France, ⁴Université Paris 13, Sorbonne Paris Cité, Paris Cité, France, ⁵Clinical research department, Clermont-Ferrand, France, ⁶Immunologie Rhumatologie, Hopital Lapeyronie, Montpellier, France, ⁷RAID working group for EULAR, Zurich, Switzerland
Background/Purpose Serum levels of vitamin D (VitD) are usually inversely correlated with RA activity. However, the prevalence of VitD deficiency does not appear to differ…
Abstract Number: 237 • 2014 ACR/ARHP Annual Meeting
Analysis of Vitamin D Receptor Gene Polymorphisms and Bone Mineral Density in a Population of Women with Rheumatoid Arthritis in Use of Steroid
Juliana Lucena¹, Fernanda G. G Chaer², Rogerio Castro Reis³ and Branca Souza¹, ¹Rheumatology, Santa Casa Sao Paulo, sao paulo, Brazil, ²Reumatologia, Santa Casa de Sao Paulo, São Paulo, Brazil, ³Reumatologia, Santa Casa de Sao Paulo, São Paulo, Brazil
Background/Purpose: To determinate the association between vitamin D receptor (VDR) gene alleles and bone mineral density (BMD), comparing a group of healthy pre-menopausal white women…
Abstract Number: 1368 • 2013 ACR/ARHP Annual Meeting
The Effect Of Vitamin D On Early Rheumatoid Arthritis: A Retrospective Cohort Analysis
Faye A H Cooles¹, Arthur G Pratt^2,3,4, Wan-Fai Ng^3,5, Terry J Aspray³ and John D Isaacs², ¹Musculoskeletal Research Group, Newcastle University, Newcastle upon Tyne, United Kingdom, ²Institute of Cellular Medicine (Musculoskeletal Research Group), NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals Foundation Trust and Newcastle University, Newcastle upon Tyne, United Kingdom, ³Musculoskeletal Directorate, The Freeman Hospital, Newcastle upon Tyne, United Kingdom, ⁴Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom, ⁵Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle upon Tyne, United Kingdom
Background/Purpose: There is increasing evidence that vitamin D has immunoregulatory properties in autoimmunity. In established rheumatoid arthritis (RA) there appears to be an inverse association…
Abstract Number: 1376 • 2013 ACR/ARHP Annual Meeting
Low Vitamin D Level Is Not Associated With Increased Incidence Of Rheumatoid Arthritis
Jonida Cote¹, Androniki Bili¹, H. Lester Kirchner² and Xiaoqin Tang³, ¹Rheumatology, Geisinger Medical Center, Danville, PA, ²Geisinger Center for Health Research, Geisinger Health System, Danville, PA, ³Biostatistics, Geisinger Center for Health Research, Danville, PA
Background/Purpose: Vitamin D is thought to be an immunomodulator able to suppress autoimmunity in rheumatoid arthritis (RA). Some reports describe an association between low vitamin…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].